These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30596676)

  • 1. Prevalence of protective tetanus antibodies and immunological response following tetanus toxoid vaccination among men seeking medical circumcision services in Uganda.
    Makumbi F; Byabagambi J; Muwanika R; Kigozi G; Gray R; Galukande M; Bagaya B; Ssebagala D; Karamagi E; Rahimzai M; Kaggwa M; Watya S; Mbonye AK; Aceng JR; Musinguzi J; Kiggundu V; Njeuhmeli E; Nanteza B
    PLoS One; 2018; 13(12):e0209167. PubMed ID: 30596676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single doses of diphtheria-tetanus-pertussis and poliomyelitis vaccines are sufficient to generate a booster-type response to tetanus in most migrant children.
    Fougère Y; El Houss S; Suris JC; Rouvenaz-Defago S; Miletto D; Von der Weid L; Willen F; Williams-Smith JA; Gehri M; Crisinel PA
    Vaccine; 2019 Oct; 37(43):6441-6446. PubMed ID: 31522805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of IgG antibodies against tetanus toxoid among different age groups in Poland.
    Śmietańska K; Rastawicki W
    Ann Agric Environ Med; 2024 Sep; 31(3):329-333. PubMed ID: 39344719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali.
    Basta NE; Borrow R; Berthe A; Onwuchekwa U; Dembélé AT; Almond R; Frankland S; Patel S; Wood D; Nascimento M; Manigart O; Trotter CL; Greenwood B; Sow SO
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S578-85. PubMed ID: 26553691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of the effect of naturally acquired maternal pertussis antibodies and antenatal vaccination induced maternal tetanus antibodies on infant's antibody secreting lymphocyte responses and circulating plasma antibody levels.
    Ahmad SM; Alam J; Afsar NA; Huda N; Kabir Y; Qadri F; Raqib R; Stephensen CB
    Hum Vaccin Immunother; 2016 Apr; 12(4):886-93. PubMed ID: 27176823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.
    Mizuno Y; Yamamoto A; Komiya T; Takeshita N; Takahashi M
    J Infect Chemother; 2014 Jan; 20(1):35-7. PubMed ID: 24462422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closing the Gap toward Zero Tetanus Infection for Voluntary Medical Male Circumcision: Seven Case Reports and a Review of the Literature.
    Galukande M; Were LF; Kigozi J; Kahendeke C; Muganzi A; Kambugu A
    Surg Infect (Larchmt); 2020 Sep; 21(7):599-607. PubMed ID: 32609063
    [No Abstract]   [Full Text] [Related]  

  • 8. Subnormal and waning immunity to tetanus toxoid in previously vaccinated HIV-infected children and response to booster doses of the vaccine.
    Choudhury SA; Matin F
    Int J Infect Dis; 2013 Dec; 17(12):e1249-51. PubMed ID: 24139228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV.
    Talesnik E; Vial PA; Labarca J; Méndez C; Soza X
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):471-7. PubMed ID: 9859960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal antibodies against tetanus toxoid do not inhibit potency of antibody responses to autologous antigen in newborn rhesus monkeys.
    Veazey RS; Lu Y; Xu H; Ziani W; Doyle-Meyers LA; Ratterree MS; Wang X
    J Med Primatol; 2018 Feb; 47(1):35-39. PubMed ID: 28585307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing immune competence in pigs by immunization with tetanus toxoid.
    Gimsa U; Tuchscherer A; Gimsa J; Tuchscherer M
    Animal; 2018 Jan; 12(1):116-121. PubMed ID: 28554336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents.
    Hanvatananukul P; Prasarakee C; Sarachai S; Aurpibul L; Sintupat K; Khampan R; Saheng J; Sudjaritruk T
    Int J Infect Dis; 2020 Jul; 96():422-430. PubMed ID: 32387447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of diphtheria and tetanus vaccination in Gaza, Palestine.
    Al Aswad IH; Shubair ME
    East Mediterr Health J; 2009; 15(2):285-94. PubMed ID: 19554974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetanus IgG antibody levels in children aged 12 to 47 months in Turkey.
    Yildirim RC; Yilmaz N; Yildirim U; Aksakal FN
    Am J Infect Control; 2001 Apr; 29(2):120-3. PubMed ID: 11287881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus.
    Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
    Anal Bioanal Chem; 2017 Jun; 409(15):3831-3842. PubMed ID: 28374129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid.
    Riner DK; Ndombi EM; Carter JM; Omondi A; Kittur N; Kavere E; Korir HK; Flaherty B; Karanja D; Colley DG
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005180. PubMed ID: 27926921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.
    van Ravenhorst MB; Marinovic AB; van der Klis FR; van Rooijen DM; van Maurik M; Stoof SP; Sanders EA; Berbers GA
    Vaccine; 2016 Dec; 34(50):6309-6315. PubMed ID: 27817957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants.
    Nohynek H; Gustafsson L; Capeding MR; Käyhty H; Olander RM; Pascualk L; Ruutu P
    Pediatr Infect Dis J; 1999 Jan; 18(1):25-30. PubMed ID: 9951976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain.
    Juan-Giner A; Domicent C; Langendorf C; Roper MH; Baoundoh P; Fermon F; Gakima P; Zipursky S; Tamadji M; Grais RF
    Vaccine; 2014 Oct; 32(47):6220-6. PubMed ID: 25261378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
    Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
    Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.